Over the past decade, several epidemiological studies have reported the association regarding XRCC1 polymorphisms and thyroid cancer risk [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26]. This evidence concerns the gene XRCC1 and thyroid gland carcinoma.